P256: High disease burden of CROHN'S DISEASE (CD) in a Latin American IBD reference centerECCO'21 VirtualYear: 2021
Authors: Sambuelli, A.(1);Gil , A.(1);Negreira , S.(1);Tirado , P.(1);Huernos, S.(1);Goncalves , S.(1);Lakatos , P.(2,3);
(1)IBD section - Bonorino Udaondo Hospital, Clinical Department, Buenos Aires, Argentina;(2)McGill University Health Centre- Montreal General Hospital, IBD Center, Montreal, Canada;(3)Semmelweis University, 1st Department of Medicine, Budapest, Hungary
P257: Assessment of the nutritional status of pediatric Inflammatory Bowel Disease patients according to disease activity.ECCO'21 VirtualYear: 2021
Authors: Palomino Pérez, L.M.(1);Velasco Rodríguez-Belvis , M.(1);Cañedo Villaroya, E.(1);Vazquez Gómez, J.A.(1);Muñoz Codoceo, R.A.(1);
(1)Hospital Infantil Universitario Niño Jesús, Paediatric Gastroenterology and Nutrition, Madrid, Spain
P258: Rates of admission of acute IBD flares during the COVID-19 pandemic in a tertiary healthcare settingECCO'21 VirtualYear: 2021
Authors: Hazel, K.(1);Glynn, E.(1);Boland, K.(1);O'Toole, A.(1);
(1)Beaumont Hospital, Department of Gastroenterology, Dublin, Ireland
P259: Safety, tolerability and pharmacokinetics of BT051, an oral inhibitor of neutrophil migration and activation in clinical development for Inflammatory Bowel DiseaseECCO'21 VirtualYear: 2021
Authors: Murphy, C.(1);Stevens, C.(2);Hershberger, E.(2);Quintas, M.(2);Miller, B.(2);Ghahramani, P.(3);
(1)Bacainn Therapeutics, Research and Development, Concord, United States;(2)Bacainn Therapeutics, Clinical Development, Concord, United States;(3)Inncelerex- LLC, Pharmacology, Weehawken, United States
P260: An analysis of non-melanoma skin cancer rates in the tofacitinib Ulcerative Colitis clinical programmeECCO'21 VirtualYear: 2021
Authors: Sands, B.E.(1);Cohen, R.D.(2);Ha, C.(3);Reinisch, W.(4);Salese, L.(5);Mundayat, R.(6);Lawendy, N.(5);Panés, J.(7);
(1)Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York- New York, United States;(2)Inflammatory Bowel Disease Center, University of Chicago Medicine, Chicago- Illinois, United States;(3)Inflammatory Bowel Disease Center, Cedars-Sinai Medical Center, Los Angeles- California, United States;(4)-, Medical University of Vienna, Vienna, Austria;(5)Pfizer Inc, Collegeville, Pennsylvania, United States;(6)Pfizer Inc, New York, New York, United States;(7)Department of Gastroenterology, Hospital Clínic de Barcelona- IDIBAPS- CIBERehd, Barcelona, Spain
P261: Predictors and outcomes of ustekinumab dose escalation to every 4 or every 6 weeks in ulcerative colitis: a multicenter cohort study in the United StatesECCO'21 VirtualYear: 2021
Authors: Dalal, R.(1);Esckilsen, S.(2);Barnes, E.(3);Pruce, J.(1);Marcus, J.(1);Allegretti, J.(1);
(1)Brigham and Women's Hospital- Harvard Medical School, Gastroenterology- Hepatology and Endoscopy, Boston- MA, United States;(2)University of North Carolina at Chapel Hill, Medicine, Chapel Hill- NC, United States;(3)University of North Carolina at Chapel Hill, Gastroenterology and Hepatology, Chapel Hill- NC, United States
P262: Effectiveness and safety of ustekinumab in elderly patients: Real world evidence from ENEIDA registryECCO'21 VirtualYear: 2021
Authors: Casas Deza, D.(1);Lamuela Calvo, L.J.(1);Arbonés Mainar, J.M.(2);Ricart, E.(3);Gisbert, J.P.(4);Rivero Tirado, M.(5);Sanchez Rodríguez, E.(6);Sicilia, B.(7);Gutierrez Casbas, A.(8);Merino Ochoa, O.(9);Márquez, L.(10);Laredo de la Torre, V.(11);Martin Arranz, M.D.(12);Lopez Serrano, P.(13);Riestra Menéndez, S.(14);Gonzalez Muñoza, C.(15);de Castro Parga, L.(16);Calvo Moya, M.(17);Garcia Alonso, J.(18);Esteve, M.(19);Iborra Colomino, M.(20);Dura Gil, M.(21);Barreiro de Acosta, M.(22);Lorente Poyatos, R.(23);Manceñido, N.(24);Caballo, B.(3);Calafat, M.(25);Rodríguez Lago, I.(26);Guardiola Capo, J.(27);Morales Alvarado, V.J.(28);Tardillo, C.(29);Bujanda, L.(30);Muñoz Nuñez, J.F.(31);Ber Nieto, Y.(32);Bermejo, F.(33);Chaparro, M.(4);Almela, P.(34);Navarro, M.(35);Domènech, E.(36);García López, S.(1);
(1)Hospital Universitario Miguel Servet, Servicio de Aparato Digestivo, Zaragoza, Spain;(2)Instituto Aragonés de Ciencias de la Salud, Unidad de investigación traslacional, Zaragoza, Spain;(3)Hospital Clinic, Servicio de Aparato Digestivo, Barcelona, Spain;(4)Hospital Universitario La Princesa, Servicio de Aparato Digestivo, Madrid, Spain;(5)Hospital Universitario Marqués de Valdecilla, Servicio de Aparato Digestivo, Santander, Spain;(6)Hospital Universitario Ramón y Cajal, Servicio de Aparato Digestivo, Madrid, Spain;(7)Hospital Universitario de Burgos, Servicio de Aparato Digestivo, Burgos, Spain;(8)Hospital General de Alicante, Servicio de Aparato Digestivo, Alicante, Spain;(9)Hospital Universitario de Cruces, Servicio de Aparato Digestivo, Baracaldo, Spain;(10)Hospital del Mar, Servicio de Aparato Digestivo, Barcelona, Spain;(11)Hospital Clínico Universitario Lozano Blesa, Servicio de Aparato Digestivo, Zaragoza, Spain;(12)Hospital Universitario La Paz, Servicio de Aparato Digestivo, Madrid, Spain;(13)Hospital Universitario Fundación de Alcorcón, Servicio de Aparato Digestivo, Alcorcón, Spain;(14)Hospital Universitario Central de Asturias, Servicio de Aparato Digestivo, Oviedo, Spain;(15)Hospital de la Santa Creu i Sant Pau, Servicio de Aparato Digestivo, Barcelona, Spain;(16)Complexo Hospitalario Universitario de Vigo, Servicio de Aparato Digestivo, Vigo, Spain;(17)Hospital Puerta del Hierro, Servicio de Aparato Digestivo, Madrid, Spain;(18)Hospital Universitario Rio Hortega, Servicio de Aparato Digestivo, Valladolid, Spain;(19)Hospital Mutua de Terrasa, Servicio de Aparato Digestivo, Terrasa, Spain;(20)Hospital Universitario La Fe, Servicio de Aparato Digestivo, Valencia, Spain;(21)Hospital Clínico Universitario de Valladolid, Servicio de Aparato Digestivo, Valladolid, Spain;(22)Hospital Universitario de Santiago, Servicio de Aparato Digestivo, Santiago de Compostela, Spain;(23)Hospital General de Ciudad Real, Servicio de Aparato Digestivo, Ciudad Real, Spain;(24)Hospital Infanta Sofía, Servicio de Aparato Digestivo, San Sebastián de los Reyes, Spain;(25)Hospital universitario German Trias i Pujol, Badalona, Badalona, Spain;(26)Hospital de Galdakao, Servicio de Aparato Digestivo, Galdakao, Spain;(27)Hospital Universitario de Bellvitge, Servicio de aparato digestivo, Hospitalet del Llobregat, Spain;(28)Hospital General de Granollers, Servicio de Aparato Digestivo, Granollers, Spain;(29)Hospital Nuestra Señora de la Candelaria, Servicio de Aparato Digestivo, Santa Cruz de Tenerife, Spain;(30)Hospital de Donostia, Servicio de Aparato Digestivo, San Sebastian, Spain;(31)Hospital Universitario de Salamanca, Servicio de Aparato Digestivo, Salamanca, Spain;(32)Hospital San Jorge, Servicio de Aparato digestivo, Huesca, Spain;(33)Hospital Universitario de Fuenlabrada, Servicio de Aparato Digestivo, Fuenlabrada, Spain;(34)Hospital General de Castellón, Servicio de Aparato Digestivo, Castellón, Spain;(35)Hospital Moises Broggi, Servicio de Aparato digestivo, San Juan Despí, Spain;(36)Hospital Universitario German Trias i Pujol, Servicio de Aparato Digestivo, Badalona, Spain; on behalf of the ENEIDA registry of GETECCU.
P263: Influence of Crohn´s Disease phenotype in the retention rate of ustekinumab treatment: SUSTAIN StudyECCO'21 VirtualYear: 2021
Authors: Chaparro, M.(1);Bastón Rey, I.(2);Fernández-Salgado, E.(3);González García, J.(4);Ramos, L.(5);Diz-Lois Palomares, M.T.(6);Argüelles, F.(7);Iglesias Flores, E.(8);Cabelo, M.(9);Rubio Iturria, S.(10);Núñez Ortiz, A.(11);Charro, M.(12);Ginard, D.(13);Dueñas Sadornil, C.(14);Merino Ochoa, O.(15);David, B.(16);Iyo, E.(17);Gutiérrez Casbas, A.(18);Ramírez de la Piscina, P.(19);Boscá-Watts, M.M.(20);Arroyo, M.(21);García, M.J.(22);Hinojosa, E.(23);Gordillo, J.(24);Martínez Montiel, P.(25);Velayos Jiménez, B.(26);Quílez Ivorra, C.(27);Vázque morón, J.M.(28);Huguet, J.M.(29);González Lama, Y.(30);Muñagorri Santos, A.I.(31);Amo, V.M.(32);Martín Arranz, M.D.(33);Bermejo, F.(34);Martínez Cadilla, J.(35);Fradejas Salazar, P.(36);Novella, C.(37);Vispo, E.(37);Barreiro-de Acosta, M.(2);P. Gisbert, J.(1);
(1)Hospital Universitario de La Princesa- Instituto de Investigación Sanitaria Princesa IIS-IP- Universidad Autónoma de Madrid and Centro de Investigación Biomédica en Red de Enfermedades Hepaticas y Digestivas CIBERehd, Gastroenterology, Madrid, Spain;(2)Complejo Hospitalario Universitario de Santiago, Gastroenterology, Santiago de Compostela, Spain;(3)Complejo Hospitalario de Pontevedra, Gastroenterology, Pontevedra, Spain;(4)Hospital Público Comarcal la Inmaculada, Gastroenterology, Almería, Spain;(5)Hospital Universitario de Canarias, Gastroenterology, Tenerife, Spain;(6)Hospital Universitario A Coruña, Gastroenterology, A Coruña, Spain;(7)Hospital Universitario Virgen Macarena- Facultad de Medicina- Universidad de Sevilla, Gastroenterology, Sevilla, Spain;(8)Hospital Universitario Reina Sofía- Universidad de Córdoba- Instituto Maimónides de Investigación Biomédica de Córdoba, Gastroenterology, Córdoba, Spain;(9)Hospital Universitario Virgen de Valme, Gastroenterology, Sevilla, Spain;(10)Complejo Hospitalario de Navarra, Gastroenterology, Pamplona, Spain;(11)Hospital Universitario Virgen del Rocío, Gastroenterology, Sevilla, Spain;(12)Hospital de Barbastro, Gastroenterolgy, Barbastro, Spain;(13)Hospital Universitario Son Espases, Gastroenterology, Palma de Mallorca, Spain;(14)Hospital San Pedro de Álcantara, Gastroenteroloy, Cáceres, Spain;(15)Hospital Universitario Cruces, Gastroenterology, Barakaldo, Spain;(16)Hospital Universitari de Girona Doctor Josep Trueta, Gastroenterology, Girona, Spain;(17)Hospital Comarcal de Inca, Gastroenterology, Inca, Spain;(18)Hospital General Universitario de Alicante- Instituto de Investigación Sanitaria y Biomédica de Alicante ISABIAL and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd- Madrid, Gastroenterology, Alicante, Spain;(19)Hospital Universitario de Araba-Txagorritxu, Gastroenterology, Araba-Txagorritxu, Spain;(20)Hospital Clínico Universitario de Valencia, Gastroenterology, Valencia, Spain;(21)Hospital Clínico Universitario Lozano Blesa, Gastroenterology, Zaragoza, Spain;(22)Hospital Universitario Marqués de Valdecilla- IDIVAL, Gastroenterolory, Santander, Spain;(23)Hospital de Manises, Gastroenterology, Manises, Spain;(24)Hospital de la Santa Creu i Sant Pau, Gastroenterology, Barcelona, Spain;(25)Hospital Universitario 12 de Octubre, Gastroenterology, Madrid, Spain;(26)Hospital Clínico Universitario de Valladolid, Gastroenterology, Valladolid, Spain;(27)Hospital Marina Baixa, Gastroenterology, Villajoyosa, Spain;(28)Hospital Universitario Juan Ramón Jiménez, Gastroenterology, Huelva, Spain;(29)Hospital General Universitario de Valencia, Gastroenterology, Valencia, Spain;(30)Hospital Universitario Puerta de Hierro, Gastroenterology, Majadahonda, Spain;(31)Hospital Universitario de Donostia, Gastroenterology, San Sebastián, Spain;(32)Hospital Regional de Málaga, Gastroenterology, Málaga, Spain;(33)Hospital Universitario de La Paz- Instituto de Investigación Sanitaria del Hospital La Paz IdiPaz- Facultad de Medicina- Universidad Autónoma de Madrid, Gastroenterology, Madrid, Spain;(34)Hospital Universitario de Fuenlabrada- Instiuto de Investigación Sanitaria del Hospital La Paz IdiPaz, Gastroenterology, Madrid, Spain;(35)Hospital Álvaro Cunqueiro, Gastroenterology, Vigo, Spain;(36)Hospital Virgen de la Concha, Gastroenterology, Zamora, Spain;(37)Janssen Medical Department, Gastroenterology, Madrid, Spain
P264: Impact of the HLA-DQ1*05 alelle on the initial response to infliximab in patients with Inflammatory Bowel DiseaseECCO'21 VirtualYear: 2021
Authors: Suris Marin, G.(1);Santacana, E.(2);Padullés, N.(2);Padró, A.(3);Serra, K.(1);Ruiz, A.(1);Blat, R.(1);Arajol, C.(1);Sanchez, E.(1);Berrozpe, A.(1);Rodríguez-Alonso, L.(1);Rodríguez-Moranta, F.(1);Guardiola, J.(1);
(1)Hospital Universitari de Bellvitge, Gastroenterology, Barcelona, Spain;(2)Hospital Universitari de Bellvitge, Pharmacology department, Barcelona, Spain;(3)Hospital Universitari de Bellvitge, Genetic Department, Barcelona, Spain
P266: The impact of vedolizumab and ustekinumab on arthropathy and arthralgia in IBD patients: a real-life multicentric cohort studyECCO'21 VirtualYear: 2021
Authors: Truyens, M.(1,2,3,4);De Galan, C.(1,3,4);Peeters, H.(5);Mesonero Gismero, F.(6);Elorza, A.(7);Torres, P.(8);Vandermeulen, L.(9);Jauregui Amezaga, A.(10);Ferreiro-Iglesias, R.(11);Holvoet, T.(12);Zabana, Y.(13,14);Peries Reverter, L.(15);Geldof, J.(1,2);Varkas, G.(4,16);De Vos, M.(1,2,3);Lobaton, T.(1,2);
(1)Ghent University, Department of Internal Medicine and Pediatrics, Ghent, Belgium;(2)University Hospital Ghent, Department of Gastroenterology, Ghent, Belgium;(3)Ghent University, Ghent Gut Inflammation Group GGIG, Ghent, Belgium;(4)Ghent University, VIB center for Inflammation Research IRC, Ghent, Belgium;(5)AZ Sint Lucas, Department of Gastroenterology, Ghent, Belgium;(6)Hospital Ramon y Cajal, Department of Gastroenterology, Madrid, Spain;(7)Hospital de Galdakao, Department of Gastroenterology, Bilbao, Spain;(8)Hospital Universitari Germans Trias i Pujol, Department of Gastroenterology, Barcelona, Spain;(9)Vrije Universiteit Brussel VUB - Universitair Ziekenhuis Brussel, Department of Gastroenterology, Brussels, Belgium;(10)University Hospital Antwerp, Department of Gastroenterology, Antwerp, Belgium;(11)Hospital Clínico Universitario de Santiago, Department of Gastroenterology, Santiago de Compostela, Spain;(12)AZ Nikolaas, Department of Gastroenterology, Sint-Niklaas, Belgium;(13)Hospital Universitari Mútua de Terrassa, Department of Gastroenterology, Barcelona, Spain;(14)Hospital Universitari Mútua de Terrassa, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd, Barcelona, Spain;(15)Hospital Universitari de Girona, Department of Gastroenterology, Girona, Spain;(16)University Hospital Ghent, Department of Rheumatology, Ghent, Belgium
P267: Sequencing of anti-TNF agents and gut-selective anti-lymphocyte trafficking (GSALT) therapy in the treatment of Crohn’s disease (CD)ECCO'21 VirtualYear: 2021
Authors: Huang, Z.(1);Ba, Y.(1);Kamble, P.(1);Wang, S.(1);
(1)Takeda, Gastroenterology- Global Outcomes, Cambridge, United States
P268: Ileal Pouch-Anal Anastomosis Complications and Pouch Failure: A Systematic Review and Meta-AnalysisECCO'21 VirtualYear: 2021
Authors: Heuthorst, L.(1);Wasmann, K.(1);Reijntjes, M.(1);Hompes, R.(1);Buskens, C.(1);Bemelman, W.(1);
(1)Amsterdam UMC- location AMC, Surgery, Amsterdam, The Netherlands
P269: Real-world impact of biological therapies on work impairment and quality of life in Inflammatory Bowel Disease patients.ECCO'21 VirtualYear: 2021
Authors: Thomas, P.(1);Den Broeder, N.(2);West, R.(3);Russel, M.(4);Jansen, J.(5);Römkens, T.(6);Hoentjen, F.(2);
(1)Radboudumc, Gastroenterology, Nijmegen, The Netherlands;(2)Radboudumc, Gastroenterology and Hepatology, Nijmegen, The Netherlands;(3)Franciscus Gasthuis & Vlietland, Gastroenterology and Hepatology, Rotterdam, The Netherlands;(4)Medisch Spectrum Twente, Gastroenterology and Hepatology, Enschede, The Netherlands;(5)Onze Lieve Vrouwe Gasthuis, Gastroenterology and Hepatology, Amsterdam, The Netherlands;(6)Jeroen Bosch Ziekenhuis, Gastroenterology and Hepatology, 's-Hertogenbosch, The Netherlands
P270: Mesenchymal stromal cells contribute to the recovery of secondary loss of response to infliximab in patients with ulcerative colitisECCO'21 VirtualYear: 2021
Authors: Knyazev, O.(1,2,3);Kagramanova, A.V.(1);Lishchinskaya, A.(1);li, I.(1);Shkurko, T.(3);Kulakov, D.(1,3);Babayan, A.(1);Zvyaglova, M.(1);Zhulina, E.(1);Parfenov, A.(1);
(1)Moscow Clinical Scientific Center named after A.S. Loginov, Department of IBD, Moscow, Russian Federation;(2)State Scientific Centre of Coloproctology named after A.N. Ryzhyh, Department of IBD, Moscow, Russian Federation;(3)Research Institute of Health Organization and Medical Management, Organization of Coloproctology, Moscow, Russian Federation
P271: Evolving Targets in Ulcerative colitis: Defining Disease Clearance in the VARSITY StudyECCO'21 VirtualYear: 2021
Authors: Danese, S.(1);Schreiber, S.(2);Loftus Jr., E.(3);Colombel, J.F.(4);Peyrin-Biroulet, L.(5);Agboton, C.(6);Lindner, D.(6);Lirio, R.(7);Sands, B.(4);
(1)Humanitas University, Department of Gastroenterology, Milan, Italy;(2)University Hospital Schleswig-Holstein, Clinic for Internal Medicine, Kiel, Germany;(3)Mayo Clinic College of Medicine, Department of Internal Medicine, Rochester MN, United States;(4)Icahn School of Medicine at Mount Sinai, Department of Gastroenterology, New York, United States;(5)Nancy University Hospital, Department of Gastroenterology, Nancy, France;(6)Takeda Pharmaceuticals, Takeda, Zurich, Switzerland;(7)Takeda Pharmaceuticals USA Inc, Takeda, Cambridge, United States
P272: Tofacitinib as salvage therapy for patients hospitalized with refractory severe active ulcerative colitis: a GETAID multicenter prospective/retrospective cohortECCO'21 VirtualYear: 2021
Authors: Uzzan, M.(1);Bresteau, C.(2);Laharie, D.(3);Stefanescu, C.(4);Carbonnel, F.(2);Serrero, M.(5);Viennot, S.(6);Nachury, M.(7);Amiot, A.(8);Altwegg, R.(9);Picon, L.(10);Nahon, S.(11);Vuitton, L.(12);Ah Soune, P.(13);Kirchgesner, J.(14);Peyrin-Biroulet, L.(15);Bouhnik, Y.(4);
(1)Hôpital Beaujon- APHP, Gastroenterology- IBD unit, Paris, France;(2)CHU Kremlin Bicêtre, Gastroenterology, Kremlin Bicetre, France;(3)CHU Bordeaux, Gastroenterology, Bordeaux, France;(4)Hopital Beaujon, Gastroenterology, Clichy, France;(5)Centre est Hôpital Nord, Gastroenterology, Marseille, France;(6)CHU Caen, Gastroenterology, Caen, France;(7)CHRU Lille, Gastroenterology, Lille, France;(8)Hopital Henri Mondor, Gastroenterology, Creteil, France;(9)CHU Montpellier, Gastroenterology, Montpellier, France;(10)CHU Tours, Gastroenterology, Tours, France;(11)CH Montfermeil, Gastroenterology, Montfermeil, France;(12)CHU Besancon, Gastroenterology, Besancon, France;(13)CH Toulon, Gastroenterology, Toulon, France;(14)Hopital Saint Antoine- APHP, Gastroenterology, Paris, France;(15)CHRU Nancy, Gastroenterology, Nancy, France
P273: The duration of clinical remission in patients with Crohn's disease depends on the frequency of administration of mesenchymal stromal cells of the bone marrowECCO'21 VirtualYear: 2021
Authors: Knyazev, O.(1,2,3);Kagramanova, A.V.(1);Lishchinskaya, A.(1);Li, I.(1);Shkurko, T.(2);Veselov, A.(2);Fadeeva, N.(4);Zhulina, E.(4);Parfenov, A.(1);
(1)Moscow Clinical Scientific Center named after A. S. Loginov, Department of IBD, Moscow, Russian Federation;(2)Research Institute of Health Organization and Medical Management, Organization of Coloproctology, Moscow, Russian Federation;(3)State Scientific Centre of Coloproctology named after A.N. Ryzhyh, Department of IBD, Moscow, Russian Federation;(4)Moscow Clinical Scientific Center named after A.S. Loginov, Department of IBD, Moscow, Russian Federation
P274: Drug utilization of biologic therapy in Crohn’s disease and ulcerative colitis: A population based Danish cohort study 2015-2018ECCO'21 VirtualYear: 2021
Authors: Jensen, K.(1);Jensen, C.B.(1);Wennerström, C.(2);Sommer, K.J.(3);Burisch, J.(4);Petersen, J.(1);
(1)Center for Clinical Research and Prevention- Frederiksberg Hospital, Copenhagen Phase IV Unit Phase4Cph, Frederiksberg, Denmark;(2)Janssen Cilag AB, Nordic Medical Operations, Solna, Sweden;(3)Janssen-Cilag A/S, Medical Affairs, Birkerød, Denmark;(4)Hvidovre Hospital, Gastrounit- Medical Division, Hvidovre, Denmark
P275: Course of COVID-19 in patients with Inflammatory Bowel Diseases treated with biologics: the Israeli experienceECCO'21 VirtualYear: 2021
Authors: Lichtenstein, L.(1);Koslowsky, B.(2);Avni-Biron, I.(3);Ovadia, B.(4);Ben-Bassat, O.(5);Naftali, T.(6);Kopylov, U.(7);Haberman, Y.(7);Banai Eran, H.(3);Eliakim, R.(7);Lahat-Zok, A.(7);Hirsch, A.(8);Zittan, E.(9);Maharshak, N.(8);Waterman, M.(10);Israeli, E.(11);Goren, I.(3);Ollech, J.E.(3);Yanai, H.(3);Ungar, B.(7);Avidan, B.(7);Ben Hur, D.(12);Melamud, B.(11);Segol, O.(12);Shalem, Z.(13);Dotan, I.(3);Odes, S.H.(14);Ben-Horin, S.(7);Snir, Y.(3);Milgrom, Y.(15);Broide, E.(13);Goldin, E.(2);Delgado, S.(1);Ron, Y.(8);Cohen, N.A.(8);Maoz, E.(16);Zborovski, M.(17);Odeh, S.(18);Abu Freha, N.(19);Bar-Gil Shitrit, A.(2);
(1)Assuta Medical Center, Gastroenterology, Ashdod, Israel;(2)Shaare Zedek Medical Center, Digestive Diseases Institute, Jerusalem, Israel;(3)Rabin Medical Center, Division of Gastroenterology, Petah Tikva, Israel;(4)Hillel Yaffe Medical Center, Gastroenterology, Hadera, Israel;(5)Barzilai Medical Center, Gastroenterology, Ashkelon, Israel;(6)Meir Medical Center, Gastroenterology, Kfar Saba, Israel;(7)The Chaim Sheba Medical Center, Gastroenterology, Tel Hashomer, Israel;(8)Tel Aviv Sourasky Medical Center Ichilov, Gastroenterology, Tel Aviv, Israel;(9)Ha`emek Medical Center, Gastroenterology, Afula, Israel;(10)Rambam Medical Center, Gastroenterology, Haifa, Israel;(11)Wolfson Medical Center, Gastroenterology, Holon, Israel;(12)Lady Davis Carmel Medical Center, Gastroenterology, Haifa, Israel;(13)Shamir Medical Center Assaf Harofeh, Gastrenterology, Be'er Ya'akov, Israel;(14)Mayanei HaYeshua Medical Center, Gastroenterology, Bnei Brak, Israel;(15)Hadassah Medical Center, Gastroenterology, Jerusalem, Israel;(16)Clalit Health Services, Gastroenterology, Tel Aviv, Israel;(17)Clalit Health Cervices, Gastoenterology, Ashdod, Israel;(18)Bnei Zion, Gastroenterology, Haifa, Israel;(19)Soroka Medical Center, Gastroenterology, Beer Sheva, Israel; and Eyal Shachar Yehuda Chowers Tal Engel Hila Reiss Arie Segal Adar Zinger On behalf of the Israeli IBD society
P276: Influence of vedolizumab on extraintestinal manifestations in Inflammatory Bowel Disease: a nationwide multicenter study of the GETECCU Eneida registryECCO'21 VirtualYear: 2021
Authors: Pérez Galindo, P.(1);Gisbert, J.P.(2);Carrillo-Palau, M.(3);Bertoletti, F.(4);González-Vivó, M.(5);Ferrer, J.A.(6);Pajares, R.(7);Merino, O.(8);Castaño, A.(9);Chaparro, M.(2);Calvo, M.(10);Barreiro-de-Acosta, M.(11);Rodríguez, A.(12);Lorente, R.H.(13);Algaba, A.(14);Riado, D.(6);Vela, M.(15);De-la-Maza, S.(16);Llaó, J.(17);Vega, P.(18);Utrilla, A.(19);Almela, P.(20);Carpio, D.(1);
(1)Complexo Hospitalario Universitario de Pontevedra, Servicio de Aparato Digestivo, Pontevedra, Spain;(2)Hospital Universitario de La Princesa- Instituto de Investigación Sanitaria Princesa IIS-IP- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Servicio de Aparato Digestivo, Madrid, Spain;(3)Hospital Universitario de Canarias, Servicio de Aparato Digestivo, Tenerife, Spain;(4)Hospital de la Santa Creu i Sant Pau, Servicio de Aparato Digestivo, Barcelona, Spain;(5)Hospital del Mar, Servicio de Aparato Digestivo, Barcelona, Spain;(6)Hospital Universitario Fundación Alcorcón, Servicio de Aparato Digestivo, Alcorcón, Spain;(7)Hospital Universitario Infanta Sofía, Servicio de Aparato Digestivo, San Sebastián de los Reyes, Spain;(8)Hospital Universitario Cruces, Servicio de Aparato Digestivo, Baracaldo, Spain;(9)Hospital Universitario Central de Asturias, Servicio de Aparato Digestivo, Oviedo, Spain;(10)Hospital Universitario Puerta de Hierro, Servicio de Aparato Digestivo, Majadahonda, Spain;(11)Hospital Clínico Universitario de Santiago de Compostela, Servicio de Aparato Digestivo, Santiago de Compostela, Spain;(12)Hospital General Universitario de Alicante, Servicio de Aparato Digestivo, Alicante, Spain;(13)Hospital General Universitario de Ciudad Real, Servicio de Aparato Digestivo, Ciudad Real, Spain;(14)Hospital Universitario de Fuenlabrada, Servicio de Aparato Digestivo, Fuenlabrada, Spain;(15)Hospital Universitario Nuestra Señora de Candelaria, Servicio de Aparato Digestivo, Tenerife, Spain;(16)Hospital Universitario de Basurto, Servicio de Aparato Digestivo, Bilbao, Spain;(17)Althaia Xarxa Assistencial Universitària de Manresa, Servicio de Aparato Digestivo, Manresa, Spain;(18)Complexo Hospitalario Universitario de Ourense, Servicio de Aparato Digestivo, Ourense, Spain;(19)Hospital General San Jorge, Servicio de Aparato Digestivo, Huesca, Spain;(20)Hospital General Universitario de Castellón, Servicio de Aparato Digestivo, Castellón, Spain